DATA DRIVEN PATIENT ACQUISITION
Revolutionizing Patient Acquisition through Data-Driven Insights
Decision Doc MX emerges as a beacon of innovation, transforming patient acquisition with its data-driven approach. Understanding the pivotal role that data plays in healthcare, we emphasize the unparalleled benefits of maximum data utilization. At the heart of our mission is the belief that doctors can provide superior medical care when armed with comprehensive patient information, gleaned not just from the first visit but through ongoing data accumulation. This paradigm shift towards a more data-centric approach not only facilitates better immediate medical decisions but also ensures the long-term well-being of patients under a doctor's care. However, the journey to optimal patient acquisition is not without its challenges.
Traditional marketing tactics often leave healthcare professionals grappling with the struggle of finding new patients, with the average marketing company bringing in a mere 30 patients a month. Decision Doc MX introduces an innovative solution, allowing practitioners to pay per new patient while addressing the core question: How much would you pay for a guaranteed influx of new patients? Join us as we delve into the nuances of data-driven patient acquisition, dissecting the traditional marketing pains and exploring the distinguishing factors that set doctors apart in the eyes of their patients—be it their educational background, experience, or the array of services they offer. Welcome to a future where informed decisions pave the way for superior healthcare.
BENEFITS OF MAXIMUM DATA
Doctors learn the most about new patients from first visit
More data helps practice better medicine
Better long term care of patients
PAINS OF NEW PATIENT MARKETING
Struggle of finding new patients (average marketing company brings in 30 a month)
What if you could pay per new patient that walks in? How much would you pay?
TRADITIONAL MARKETING TACTICS
What patients see as the difference between doctors
University
Experience
Services
THE TM-FLOW MEDICAL DEVICE
TM-Flow ANS Testing Medical Device Is A Highly Comprehensive, User-friendly, Non-invasive Tool That Focuses On Early Detection And Follow-up Of Complications (Autonomic Nervous System & Vascular System) By Measuring 8 Health Risk Areas Within The Body. This ANS Testing Medical Device Effectively Measures The State Of A Patient’s Health By Screening For Hidden Causes Of Disease And Other Chronic Metabolic Diseases Such As Diabetes And Other Cardiometabolic Risks.
THIS EXAM IS PAID OUT BY MEDICARE AND MOST PRIVATE INSURANCE
The TM-Flow exam reimburses through Medicare and most private insurances. Reimbursements average between $300 to $500 per test leading to a significant increase in practice revenue. Each exam can be completed within a 15 to 20 minute scheduled event thus allowing practices the ability to do between 2 to 3 tests per hour. With a healthy internal and digital marketing strategy, we can help get your schedule filled!
THE SCIENCE OF OUR PLATFORM INCORPORATES TWO TECHNOLOGIES FOR MANAGEMENT OF OUR PROGRAMS
ANS Testing
Diagnostic Management
Encounter Form Preparation
New Patient Marketing
BIO-DATA ANALYSIS AND REIMBURSEMENT
In addition to all of the data given from the subjective intake process, we add the objective findings of the 65 ICD + modifiers of the TM-Flow. This exam analysis:
Autonomic Nervous System
Macro-vascular system
Micro-vascular system
This medical device validates over 120 bio-markers with specified CPT and ICD-10 codes reimbursable through most insurance carriers.
The codes this device use are 95923-95943-95921 and also use cardiometabolic code: 93923-93922
EARLY DETECTION AND PREVENTION
This is good medicine and will aid in the early detection of over 20 disease complications, while also validating critical next-step treatment and testing!
Heart Attack
Heart Rate Variability Issues
Cardiac Output to Body Surface Area
Abnormal LDL Cholesterol
Insulin Resistance
Diabetes with Complications
Physical and Mental Stress
Anxiety and Fatigue
Stroke
Angiotensin Activity
Atherosclerosis
Peripheral Vascular Disease
Hyperhidrosis and Hypohidrosis
Impaired Glucose Intolerance
Nerve Damage
Obesity
Amyloid Neuropathy
Asthma
Cardiovascular Associated Diseases
Idiopathic Neuropathy
Multiple System Dystrophy
Post-Partum Dysfunctions
Psychological Conditions
Pure Autonomic Failure
Sjogren’s Syndrome
ANS Testing
Diagnostic Management
Encounter Form Preparation
New Patient Marketing
THE 8 RISK FACTOR AREAS EXAMINED
System Dysfunction
Dysfunction
Dysfunction
Neuropathy
Risk
Neuropathy
Disease
Please reference the sample patient exam and the science report for a deeper dive into the clinical applications.
HEALTH RISK FACTORS DEFINED
This is good medicine and will aid in the early detection of over 20 disease complications, while also validating critical next-step treatment and testing!
1. AUTONOMOUS NERVOUS SYSTEM DYSFUNCTION RISK - ANSD
Problems with the ANS can range from mild to life-threatening. Sometimes, only one part of the nervous system is affected. In other cases, the entire ANS is affected. Some conditions are temporary and can be reversed, while others are chronic and will continue to worsen over time. Diseases such as Diabetes or Parkinson’s Disease can cause irregularities with ANS. Problems with ANS regulation often involve organ failure, or the failure of the nerves to transmit a necessary signal.
2. SUDOMOTOR DYSFUNCTION RISK - SudoD
Sudomotor dysfunction testing may indicate to physicians a patient's peripheral nerve and cardiac sympathetic dysfunction. Neuropathy is a common complication in diabetes mellitus (DM), with 60%-70% of patients affected over their lifetime. Symptoms of neuropathy is more common than clinical neuropathy. Neuropathy may remain undetected, and progress over time leading to serious complications. The most common associated clinical condition is peripheral neuropathy, affecting the feet. Autonomic nerve involvement is common but probably the most undiagnosed. Low scores in the sudomotor may lead a medical provider to look at clinical neuropathy.
3. ENDOTHELIAL DYSFUNCTION RISK - EndoD
Current evidence suggests that endothelial function is an integrative marker of the net effects of damage from traditional and emerging risk factors on the arterial wall and its intrinsic capacity for repair. Endothelial dysfunction, detected as the presence of reduced vasodilating response to endothelial stimuli, has been observed to be associated with major cardiovascular risk factors, such as aging, hyperhomocysteinemia, post menopause state, smoking, diabetes, hypercholesterolemia, and hypertension.
4. INSULIN RESISTANCE RISK - IR
Insulin resistance is defined clinically as the inability of a known quantity of exogenous or endogenous insulin to increase glucose uptake and utilization in an individual as much as it does in a normal population. Insulin resistance occurs as part of a cluster of cardiovascular metabolic abnormalities commonly referred to as "The Insulin Resistance Syndrome" or "The Metabolic Syndrome". This cluster of abnormalities may lead to the development of type 2 diabetes, accelerated atherosclerosis, hypertension or polycystic ovarian syndrome depending on the genetic background of the individual developing the insulin resistance.
HEALTH RISK FACTORS DEFINED
Here is a quick review of the health risk factors that the Dicision Doc AI Medical Device Platform report is based on.
5. CARDIOMETABOLIC RISK - CMR
The specific factors that can cause this increased risk include: obesity (particularly central), hyperglycemia, hypertension, insulin resistance and dyslipoproteinemia. When patients have one or more risk factors and are physically inactive or smoke, the cardiometabolic risk is increased even more. Medical conditions that often share the above characteristics, such as type 2 diabetes, can also increase cardiometabolic risk. The primary focus of cardiometabolic risk treatment is management of each high risk factor, including dyslipoproteinemia, hypertension, and diabetes. The management of these subjects are based principally on life style measures, but various antihypertensive, lipid-lowering, insulin sensitizing, anti-obesity and antiplatelet drugs could be helpful in reducing cardiometabolic risk.
6. PLETHYSMOGRAPHY CARDIOVASCULAR DISEASE RISK - PTG CVD
The PTG CVD risk factor is the combined total of the other seven risk factors assessments. It takes into consideration the cardiovascular as well as the autonomic nervous system (ANS) measurements.
7. CARDIAC AUTONOMIC NEUROPATHY RISK - CAN
High blood glucose levels over a period of years may cause a condition called autonomic neuropathy. This is damage to the nerves that control the regulation of involuntary function. When the nerve damage affects the heart, it is called cardiac autonomic neuropathy (CAN). CAN encompasses damage to the autonomic nerve fibers that innervate the heart and blood vessels, resulting in abnormalities in heart rate control, vascular dynamics and the body's ability to adjust blood pressure. CAN is a significant cause of morbidity and mortality associated with a high risk of cardiac arrhythmias and sudden death.
8. SMALL FIBER NEUROPATHY RISK - SFN
A small fiber neuropathy occurs when damage to the peripheral nerves predominantly or entirely affects the small myelinated fibers or unmyelinated C fibers. The specific fiber types involved in this process include both small somatic and autonomic fibers. The sensory functions of these fibers include thermal perception and nociception. These fibers are involved in many autonomic and enteric functions.
THE DECISION DOC AI MEDICAL DEVICE PLATFORM GIVES YOU A COMPLETE SOLUTION FROM PATIENT INTAKE TO ENCOUNTER FORM PREPARATION FOR BILLING.
Intake technology for validation of symptoms and medical necessity
Full TM-Flow health risk analysis display
Diagnostic conversion of Biomedical Markers from the exam into CPT and ICD language
Consolidated data on the dashboard for quick decisions and review
Encounter form preparation directly from the medical markers for billing submission
Additional qualified testing validation across 21 potential next steps
Unlimited medical devices, doctors, nurses, technicians, and other users
VALIDATION FOR ADDITIONAL NEXT STEPS TESTING
Our platform validates over 21 additional exams for potential next-steps for the physician.
INCLUDING
MRI
EEG
Blood Tests
CT Scan
NCS
A1C
Ultrasound / Vascular Studies
Thermoregulatory Sweat Tests
Angiography
Advanced ECG
Small Fiber Neuropathy Testing
Stress Tests
Chest X-Ray
Glucose Tolerance Testing
Holter Monitor
EMG
Bone Scan
Our platform Gives immediate access to the potential medical necessity for the ordering of 298+ different laboratory services found within standard Clia licensed Laboratories.
ANS Testing
Diagnostic Management
Encounter Form Preparation
New Patient Marketing
OUR NEW PATIENT MARKETING PUTS 3 TO 4 TIMES MORE MONEY INTO YOUR PRACTICE THAN ANY OTHER FIRST TIME VISIT PATIENT PROGRAM.
OUR MODEL
TM-Flow Exam $400 (National average)
Doctor time NOT required
Other New Patient Models
First Patient Visit $125
Doctor time required
AN EXAMPLE:
30 patients acquired through first time visit marketing: $3,750
30 patients acquired through the TM-Flow Health Risk Analysis:$12,000
MEDICAL INTELLIGENCE AND VALIDATION
Decision DOC AI is the central technology that empowers the rest of our software initiative in Clinical Speed. This platform was developed to give a physician the maximum visibility of a patient’s potential disease state from the subjective input at intake.
Our platform validates over 21 additional exams for potential next-steps for the physician.
There are several ways to access the evidenced data of our analysis, download patient master reports for your EHR, and a dashboard for provider quick review.
Decision DOC qualifies all of the potential CPT and ICD protocols associated with the intake qualifications. This includes research links for everything evidenced.
Our platform Gives immediate access to the potential medical necessity for the ordering of 298+ different laboratory services found within standard Clia licensed Laboratories.
Gives the intake qualifications for medical necessity to order 21 potential next steps examinations including nerve conduction studies, CAT scans, MRI, and many more.
FULLY INTEGRATED WITH THE AI DATASET OF CHATGPT 4
The Artificial Intelligence engineering world is merging with the Medial industry. We are a pioneer in this space, bringing first to market AI provider programs in treatment protocol and so much more. The AI of ChatGPT 4, the industry leading AI engine, has been fully integrated into Decision DOC AI.
Our platform generates AI for suggested treatment protocols concerning each of the initial findings mentioned in the last side generated by intake.
Our AI will generate a full list of related medications to the findings with a description of each and their benefit to the issue presented.
Our AI generates lifestyle and wellness suggestions based on the exact criteria of our intake and all other generated context.
Our AI generates example physician/patient discussions on each potential disease analysis. This gives physicians the opportunity to review and prepare to cover all necessary areas of focus in patient education.
Perspectives matter and knowing what other professionals may recommend is one of the reasons we refer patients. Our AI platform will generate opinion for most other physician taxonomies to help you decide to refer or not. Our AI engine will re-evaluate all the data from the perspective of other taxonomies for you, including Cardiology, Neurology, Oncology and several others.
Decision DOC MX solves the traditional problems of marketing with an improved first visit. Patients come in for this unique exam. Because they want the exam, all the doctor has to do is find medical necessity.
While Decision DOC AI discovers the medical necessity and intelligently presents all patient data for easy review.
DECISION DOC MX’S GOAL
150+ new patients each month
THERE ARE 2 DIFFERENT WAYS TO MARKET
Street Marketing
Web Marketing
While most companies will only do web marketing, Decision DOC MX has innovated both.
STREET MARKETING
DECISION DOC MX PERFORMS TRADITIONAL STREET MARKETING
Door Hangers
Networking Events
Etc
REWARD PROGRAM
WE REACH OUT TO LOCAL BUSINESSES TO ACQUIRE REWARD PROGRAMS
they get paid $30-$50 per patient they bring you. while mx clients build their reputations in the community
CALL CENTER DIAL IN
Each reward partner is granted a vanity number that their clients can use to call into the Decision Doc MX call center. We schedule the appointment
Call in appointments set up over the phone are $10.50each
WEB MARKETING
Referrals are still the best way to bring new patients into your practice. Online referrals also boost your website visibility more than any other action.
Social Advo is an online advocate program
Automatic postings on Facebook, X, and LinkedIn
YouTube Testimonials
Press Releases
Business Developers will write a free press release every week about your practice
SOCIAL ADVO’S POWER
Average Facebook post is seen by 12% of friends (techcrunch)
5 Social Advo partners that post once a week
40.56 * 5 =202.8 * 4.3 (weeks in a month) = 872.04 * 12 =10464.48 Impressions in 1 year
INLAND EMPIRE EXAMPLE
OUR PARTNER IN INLAND EMPIRE HAD OVER 700 LOCAL BUSINESSES WITHIN A 5-MILE RADIUS.
Within 4 weeks, over 30 partners had agreed to support the TM-Flow Exam.
One insurance company agreed to bring in 50 patients a month.
PRICES
$49,000 START UP FEE
Includes TM-Flow
Social Advo Start up
Decision Doc AI
$1,500 MO AD SPEND
$10.50 TM-FLOW PREPARATION FEE
$10.50 CLIENT ACQUISITION
YouTube
Social Advo
Ad Spend
Website
$10.50 PER CALL CENTER APPLICATION
$5 DECISION DOC AI SUBMISSION FEE
BUSINESS DEVELOPMENT
THIS IS A REQUIREMENT OF OUR MX CLIENTS WHICH REALLY MEANS THIS PROGRAM IS JUST FOR SERIOUS PLAYERS
25% over payroll + employer fees on a $25 per hr business manager on a minimum 6 month contract.
1 location 20 hrs wk.
2nd+ an additional 10 hrs wk.
Must have an onsite person that can do up to two events a month
WE ONLY WANT SERIOUS PLAYERS
DECISION DOC MX IS THE ULTIMATE NEW PATIENT ACQUISITION MODEL.
It requires replacing your current intake process with Decision DOC AI and for a practice to prepare to scale to 150+ new patients a month.